Trademark Search  /  GLYPH2BLSD

GLYPH2BLSD

● Live · Pending

U.S. federal trademark · Serial No. 99336889

Mark
GLYPH2BLSD
Status
Pending
Serial Number
99336889
Filing Date
August 14, 2025
Class(es)
Class 005, Class 035, Class 042

Owners

Seaport Therapeutics, Inc.
03 · Boston, MA, US
Seaport Therapeutics, Inc.
03 · Boston, MA, US

Goods & Services

Commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

Research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "GLYPH2BLSD" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.